本人照片


姓名:经翔

职称:主任医师

导师类型:硕士研究生导师


  1. 教育经历

1984.091989.07,天津37000cm威尼斯,临床医学系,学士


  1. 工作经历

12007.11至今,南开大学附属第三中心医院,主任医师

22002.092007.11,南开大学附属第三中心医院,副主任医师

31997.092002.09,南开大学附属第三中心医院,主治医师

41989.101997.09,南开大学附属第三中心医院,医师


  1. 研究方向(可以填写多个方向)

  1. 肝硬化背景下微小肝癌的超声造影诊断及多模态诊断

  2. 肝脏肿瘤热消融长期预后及并发症防治

  3. 肝胆疾病的介入超声诊疗

  4. 多模态融合影像技术在肝脏肿瘤热消融中的应用研究

  5. 超声造影的AI诊断研究

  6. 肝脏肿瘤热消融治疗后免疫防治的分子机制研究

  7. 肝脏肿瘤热消融后免疫联合治疗新策略探索


  1. 学术兼职

  1. 享受国务院特殊津贴专家

  2. 中华医学会超声医学分会第十届委员会常委

  3. 中华医学会超声医学分会腹部学组副组长

  4. 中国医师协会超声医师分会常委

  5. 中国医师协会超声医师分会介入专业委员会副主委

  6. 中国超声医学工程学会理事

  7. 中国超声医学工程学会介入超声专业委员会副主委

  8. 中华医学会超声医学分会介入诊疗学组委员

  9. 中国医学著作网超声医学专家委员

  10. 中国医学影像技术研究会理事、超声专业委员会常委

  11. 中国医学影像技术研究会介入超声专业、腹部超声专业常委

  12. 中国抗癌协会肿瘤影像专业委员会常委

  13. 中国临床肿瘤协会(CSCO)肿瘤消融专业委员会常委

  14. 海峡两岸医药卫生交流协会超声医学专家委员会常委

  15. 天津医师协会超声科医师分会会长

  16. 天津医学会超声分会副主委

  17. 天津市超声医学工程学会副会长

  18. 天津市超声质控指导中心副主任

  19. 天津市抗癌协会常务理事

  20. 天津市抗癌协会肿瘤影像专业委员会副主委

  21. 天津市抗癌协会肝癌专业委员会常委

  22. 国家卫健委:超声医学专科能力建设项目专家委员会委员

  23. 中国医师协会超声专业医师定期考核编委

  24. 医学参考报-超声频道常务编委

  25. 中华医学会肿瘤消融规范化治疗培训班授课专家

  26. 中国超声医师网百家讲坛专家讲师团成员

  27. 《中华超声影像学杂志》编委(2021第八届)

  28. 《中华医学超声杂志》(电子版)编委

  29. 《介入放射学杂志》编委

  30. 《中国介入影像与治疗学》常务编委 2019.03第四届

  31. 《肿瘤影像学》编委

  32. 《肝癌》编委

  33. 《国际生物医学工程》编委

  34. 《中国肿瘤临床》审稿专家

  35. 《临床肝胆病杂志》审稿专家

  36. 《肿瘤防治研究》审稿专家

  37. 《天津医药》审稿专家

  38. 天津市医疗技术临床应用能力审核专家

  39. 天津市医疗设备招标评审专家

  40. 天津市医疗事故鉴定专家


  1. 代表性学术论文

1.WuW, Jing X, Xue G, et al. A Multicenter Randomized Controlled Study ofContrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.Radiology, 2022, 212317.

2.Chen J, Jin P, Song Y, Feng L, Lu J, Chen H, Xin L, Qiu F, Cong Z,Shen J, Zhao Y, Xu W, Cai C, Zhou Y, Yang J, Zhang C, Chen Q*, JingX* and Huang P* Auto-Segmentation Ultrasound-Based RadiomicsTechnology to Stratify Patient With Diabetic Kidney Disease: AMulti-Center Retrospective Study. Frontiers in Oncology,2022, 12,876967.

3.Zhou Yan#, Yin Shanshan#, Zhao Lin, Zhang Xiang, Li Meng, DingJianmin, Yan Kun* and Jing Xiang* et al. CEUS and CT/MRI LI-RADS inassociation with serum biomarkers for differentiation of combinedhepatocellular-cholangiocarcinoma from hepatocellular carcinoma.Frontiers in Oncology, 2022, 12897090.

4.ZhouYan#, Qin Zhengyi#, Ding Jianmin, Zhao Lin, Chen Ying, Wang Fengmei*,Jing Xiang*. Risk stratification and distribution of hepatocellularcarcinomas in CEUS and CECT/MRI LI-RADS: A meta-analysis. Frontiersin Oncology, 202212873913.

5.QinZhengyi, Zhou Yan, Ding Jianmin, Zhou Hongyu, Wen Jing, Ying Chen,Xiang Jing*. Risk stratification for hepatocellular carcinoma ofcontrast-enhanced ultrasound Liver Imaging Reporting and Data SystemLI-RADSandthe diagnostic performance of LR-5 and LR-M: a systematic review andmeta-analysis. Clinical Radiology, 202277e280.

6.ZhouYan, Ding Jianmin, Qin Zhengyi, Long Lei, Zhang Xiang, Wang Fengmei*,Chen Chen, Wang Yandong, Zhou Hongyu, Jing Xiang*. Combination ofCT/MRI LI-RADS with CEUS can improve the diagnostic performance forHCCs. European Journal of Radiology, 2022, 149, 110199.

7.ZhouHongyu#, Zhou Yan#, Ding Jianmin, Chen Ying, Wen Jing, Zhao Lei,Zhang Qian, Jing Xiang*. Clinical evaluation of grayscale and linearscale hepatorenal indices for fatty liver quantification: aprospective study of a native Chinese population. AbdominalRadiology, 2022, 47, 1321.

8.DingJianmin, Qin Zhengyi, Zhou Yan, Zhou Hongyu, Zhang Qin, Wang Yandong,Jing Xiang*, Wang Fengmei. Impact of Revision of the LR-M Criteria onthe Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS.Ultrasound in Medicine & Biology, 2021, 47, 3403.

9.CaoYuting #, Zhou Yan #, Pan Jinbin#*, Zhong Xinyu, Ding Jianmin, JingXiang *, Sun Shao-Kai *. A general strategy towards an injectablemicrowave-sensitive immune hydrogel for combined percutaneousmicrowave ablation and immunotherapy. Chemical Engineering Journal,2021, 422, 130111.

10.DingJianmin#; Wang Dong#; Zhou Yan; Zhao Lin; Zhou Hongyu; Jing Xiang*;Wang Yandong. A novel mono-modality fusion imaging method based onthree-dimensional contrast-enhanced ultrasound for the evaluation ofablation margins after microwave ablation of hepatocellularcarcinoma[J]. J Gastrointest Oncol, 2021, 12, 184.

11.ZhouYan#; Zhao Lin#; Zhong Xinyu; Ding Jianmin; Zhou Hongyu; Jing Xiang*;A thermochromic tissue-mimicking phantom model for verification ofablation plans in thermal ablation. Ann Transl Med. 2021, 9, 354

12.JingXiang*, Zhou Yan, Ding Jianmin, Wang Yijun, Qin Zhengyi, WangYandong, Zhou Hongyu. The Learning Curve for Thermal Ablation ofLiver Cancers: 4,363-Session Experience for a Single Central in 18Years. Frontiers in Oncology, 2020, 10, 2244.

13.ZhouYan#, Wang Yandong#, Wang Fengmei, Zhang Xiang, Ding Jianmin, ZhouHongyu, Jing Xiang*. Additional Diagnostic Value of Fusion Imaging ofCEUS and First CEUS of Invisible Hepatic Lesions≤ 2 cm[J]. Journalof Ultrasound in Medicine, 2020401173.

14.ZhouYan#, Ding Jianmin#, Qin Zhengyi, Wang Yijun, Zhang Jiayi, JiaKefeng, Wang Yandong, Zhou Hongyu, Wang Fengmei, Jing Xiang*.Predicting the survival rate of patients with hepatocellularcarcinoma after thermal ablation by nomograms. Ann Transl Med 2020,8, 1159.

15.XinyuZhong#, Yan Zhou#, Yuting Cao, Jianmin Ding, Peng Wang, Ying Luo, HuiLiu, Zhengyan Zhu & Xiang Jing. Enhanced antitumor efficacythrough microwave ablation combined with a dendritic cell-derivedexosome vaccine in hepatocellular carcinoma, International Journal ofHyperthermia, 2020, 37, 1210

16.DingJianmin, Long Lei, Zhang Xiang, Chen Chen, Zhou Hongyu, Zhou Yan,Wang Yandong, Jing Xiang*, Ye Zhaoxiang*, Wang Fengmei.Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRILI-RADS. European Radiology, 202031847.

17.ZhouYan#, Jiang Jiapeng#, Ding Jianmin, Wang Peng, Liu Hui, Luo Ying, ZhuZhengyan, Gao Yingtang, Jing Xiang*, et al. Microwave ablationcombined with dendritic cell vaccine: a potential synergistic therapyfor hepatocellular carcinoma. International Journal Of Clinical AndExperimental Medicine, 2019, 12, 11257.

18.ZhouYan, Jing Xiang*, Zhang Xiang, Ding Jianmin, Wang Yandong, ZhouHongyu, Zhang Qin, Chen Ying, Yue Wenjun. Combining the ArterialPhase of Contrast-Enhanced Ultrasonography, Gadoxetic Acid-EnhancedMagnetic Resonance Imaging and Diffusion-Weighted Imaging in theDiagnosis of Hepatic Nodules≤ 20 mm in Patients with Cirrhosis.Ultrasound in medicine & biology, 2019, 45, 693.

19.ZhouYan, Jing Xiang*, Ding Jianmin, Wang Fengmei, Li Jun, Wang Yandong,Zhou Hongyu, Liu Baijing. Risk factors of liver dysfunction inducedby microwave ablation in patients with hepatocellual carcinoma.International Journal Of Clinical And Experimental Medicine.2018,11,10458.

20.ZhouYan, Xu Xiaolin, Ding Jianmin, Xiang Jing*, Wang Fengmei, WangYandong, Wang Peng. Dynamic changes of T-cell subsets and theirrelation with tumor recurrence after microwave ablation in patientswith hepatocellular carcinoma. Journal of Cancer research andtherapeutics. 2018,1, 40.

  1. 荣誉和奖励

获奖:

  1. 获得天津市科技进步二等奖1

  2. 获得天津市科技进步三等奖2

荣誉:

  1. 2021 天津市卫生系统优秀党员

  2. 2020 天津名医(天津市卫生健康委员会)

  3. 2019 九三学社天津市第三中心医院支社委员会“先进基层组织”“市级先进个人”

  4. 2018 “启明星”介入超声规范化培训2018卓越成就奖

  5. 2018 首届中国医师节庆祝大会:天津市医师协会评定“敬业奉献奖”“天津超声科医师协会优秀团队奖”

  6. 2018 中国杰出超声医师(中国医师协会超声医师分会)

  7. 2017 中国好医生月度人物(国家文明办、国家卫计委)

  8. 2017 国家白求恩奖章(国家人力资源和社会保障部、卫计委、中医药管理局)

  9. 2008 年度天津市五一劳动奖章先进个人(天津市总工会)


  1. 联系方式

联系邮箱:dr.jingxiang@aliyun.com

联系地址:天津市河东区津塘路83号天津市第三中心医院 超声科

XML 地图